Key result
Complex high-risk percutaneous coronary intervention in nonsurgical centres was associated with lower odds of mortality (aOR 0.7; 95% CI 0.5-0.8) compared with surgical centres.
Why the study?
Limited data are available on complex high-risk percutaneous coronary intervention trends and outcomes in nonsurgical centres, especially where most centres lack on-site surgical cover.
Does performing complex high-risk percutaneous coronary intervention (CHiP) in nonsurgical centres compared to surgical centres improve outcomes in patients with stable angina?
Cohort (n=134,730)
Yes
Does performing complex high-risk percutaneous coronary intervention (CHiP) in nonsurgical centres compared to surgical centres improve outcomes in patients with stable angina?
Complex high-risk PCI can be performed safely in nonsurgical centers with comparable or lower rates of in-hospital mortality and major bleeding compared to surgical centers.
Answers are grounded in this paper and cite their sources.
CHiP in nonsurgical centres may be feasible; observational data leave open need for RCTs before practice change.
BACKGROUND: Limited data are available on complex high-risk percutaneous coronary intervention (CHiP) trends and outcomes in nonsurgical centres (NSCs), particularly in health care systems where most centres are NSCs. METHODS: Using data from a national registry, we studied the characteristics and outcomes of CHiP procedures performed for stable angina from 2006 to 2017 according to the presence or absence of on-site surgical cover. Multivariate regression analyses and propensity score matching were used to determine risks for in-hospital death, major bleeding, and major cardiovascular or cerebral events (MACCE). RESULTS: Out of 134,730 CHiP procedures, 42,433 (31.5%) were performed in NSCs, increasing from 12.5% in 2006 to 42% in 2017. Compared with surgical centres (SCs), patients who had a CHiP procedure undertaken in NSCs were, on average, 2.4 years older and had a greater prevalence of cardiovascular risks. Common CHiP procedures performed in NSCs included poor left ventricular function (41.6%), chronic renal failure (38.8%), and chronic total occlusion percutaneous coronary intervention (31.1%). NSC-based CHiP is associated with lower odds of mortality (adjusted odds ratio [aOR] 0.7, 95% confidence interval [CI] 0.5-0.8) and major bleeding (aOR 0.7, 95% CI 0.6-0.8). In both groups, MACCE odds were similar (aOR 1.0, 95% CI 0.9-1.1). CONCLUSIONS: CHiP numbers have steadily increased in NSCs. NSC patients were older and had a higher prevalence of cardiovascular risks than SC patients. Mortality and major bleeding odds were significantly lower in those cases undertaken in NSCs, although MACCE odds were not different between the groups.
No takes yet. Share an insight, caveat, or question.
Shamkhani et al. (2024) conducted a cohort in Stable angina requiring complex high-risk percutaneous coronary intervention (n=134,730). Complex high-risk percutaneous coronary intervention in nonsurgical centres vs. Surgical centres was evaluated on In-hospital mortality (aOR 0.7, 95% CI 0.5-0.8). Complex high-risk percutaneous coronary intervention in nonsurgical centres was associated with lower odds of mortality (aOR 0.7; 95% CI 0.5-0.8) compared with surgical centres.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: